Target intelligence / Profile preview

Beta-glucan recognition protein (BGRP) (BGRP)

Target
BGRP
Molecular classification
Pattern recognition receptor, Glucan-binding protein, Innate immune receptor
01

Overview

Beta-glucan recognition proteins (BGRPs) are a family of pattern recognition receptors (PRRs) essential for the innate immune system's ability to detect fungal and certain bacterial pathogens (ResearchGate, 2012; NIH, 2015). Primarily characterized in invertebrates like insects and crustaceans, BGRPs specifically bind to beta-1,3-glucans, which are major structural components of fungal cell walls (NIH, 2010). Upon binding, these proteins trigger critical defense mechanisms, including the prophenoloxidase (proPO) activation system—leading to melanization and encapsulation of pathogens—and the Toll signaling pathway, which induces the production of antimicrobial peptides (Frontiers, 2024; NIH, 2015). In mammals, while direct BGRP homologs are absent, functional counterparts such as Dectin-1 (CLEC7A) and Complement Receptor 3 (CR3) perform analogous roles in sensing fungal infections and modulating immune responses (NIH, 2010; NIH, 2021). BGRPs and their mammalian equivalents are significant therapeutic targets; beta-glucan-based compounds like lentinan and schizophyllan are utilized as biological response modulators to enhance anti-tumor immunity and resistance to infections (NIH, 2021; MDPI, 2021). Additionally, BGRPs are employed in diagnostic assays, such as the Limulus amebocyte lysate (LAL) test, to detect systemic fungal contamination and infections (MDPI, 2021). The study of BGRPs also provides insights into the evolution of innate immunity and the development of novel antifungal strategies (ResearchGate, 2012).

Other names
Beta-1,3-glucan recognition proteinBeta-1,3-glucan binding proteinBGBPGram-negative binding protein 3GNBP3GNBP
02

Mechanism of action

Binding to beta-1,3-glucan motifs on fungal or microbial cell walls, leading to the activation of downstream immune signaling pathways such as the Toll pathway or the prophenoloxidase cascade (NIH, 2015; ResearchGate, 2012).

03

Biological functions

Immune responsePathogen recognitionSignal transductionMelanizationPhagocytosisAntimicrobial peptide production
04

Disease associations

InfectionInflammationCancerSepsisMetabolic syndrome
05

Safety considerations

Cytokine stormExcessive inflammationFalse positives in diagnostic assays (e.g., LAL assay)ImmunogenicityGastrointestinal distress
06

Interacting drugs

Lentinan

6 more in the full profile.

07

Biomarkers

Beta-glucan levels (G-test)BGRP expression levelsProphenoloxidase activityCytokine levels (IL-1, TNF-alpha)

Beyond the preview

Go deeper on Beta-glucan recognition protein (BGRP) (BGRP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-glucan recognition protein (BGRP) (BGRP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call